Vascular Liver Disease Evaluation, Follow Up and Non-Invasive Diagnostics Program

Launched by UNIVERSITY HOSPITAL, BONN · Oct 23, 2018

Keywords

ClinConnect Summary

The Vascular Liver Disease Evaluation, Follow Up and Non-Invasive Diagnostics Program is a clinical trial focused on understanding rare liver conditions known as vascular liver disorders. The goal of this study is to identify risk factors, improve methods for diagnosing these disorders, assess the effectiveness of treatments, and better predict patient outcomes. By gathering and analyzing data from patients diagnosed with vascular liver disease over a period of up to three years, the researchers aim to create updated guidelines for managing these conditions.

To participate in this trial, individuals must have a confirmed diagnosis of vascular liver disease. The study is open to all patients aged 65 and older. Participants will have their medical information carefully reviewed by a specially trained investigator, and their details will remain anonymous. Throughout the study, researchers will track clinical conditions, lab results, and treatments to help enhance the understanding and management of vascular liver disorders. This trial is currently recruiting participants who meet the eligibility criteria.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • all patients with vascular liver disease
• Exclusion Criteria:
• • patients without vascular liver disease